Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine vs sufentanil for postoperative analgesia in gynecologic laparoscopic surgery
ChiCTR2300075533Phase 4Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postoperative pain and postoperative nausea and vomiting (PONV) (2 arms), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Primary endpoint: VAS grade of postoperative nausea and vomiting (PONV). Planned start Sep 2023; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2300075533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300075533.